Bengaluru, India

Indasi J Gopi Kumar

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Indasi J Gopi Kumar. Retrieved from https://idiyas.com/inventor/indasi-j-gopi-kumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Indasi J Gopi Kumar: Innovator in Antiviral Compounds

Introduction

Indasi J Gopi Kumar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antiviral research, particularly in the development of compounds targeting the Hepatitis C virus.

Latest Patents

Indasi holds 1 patent for his work on Hepatitis C virus inhibitors. This patent focuses on antiviral compounds that inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV). The disclosure includes combinations of compounds, compositions comprising these combinations, and methods for effectively inhibiting the NS5A protein's function.

Career Highlights

Indasi is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in antiviral therapies. His work is crucial in the ongoing battle against viral infections, particularly those caused by Hepatitis C.

Collaborations

Indasi has collaborated with several esteemed colleagues, including Piyasena Hewawasam and Omar D Lopez. These partnerships enhance the research and development of innovative antiviral solutions.

Conclusion

Indasi J Gopi Kumar's contributions to antiviral research, particularly through his patent on Hepatitis C virus inhibitors, highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in antiviral therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…